Tag: NASDAQ TRVN

Business

Trevena Inc (NASDAQ: TRVN) Begins A Trial To Evaluate OLINVYK Physiological Impact On Respiratory Function In Obese/ Elderly People

Trevena Inc (NASDAQ: TRVN) commenced a clinical trial evaluating OLINVYK’s physiological impact on respiratory function in obese and elderly subjects.  A leading clinical researcher and professor (Anesthesiology) – Albert Dahan, is leading this evaluation study. It is based on the previously completed work executed by the company in collaboration with Dahan’s […]